Dr. Zaineb H. Makhzoumi, MD

Dr. Makhzoumi practices at University of Maryland Surgical Center in Baltimore, Maryland.

Dr. Makhzoumi's NPI, 1407014913, was assigned on May 30, 2008. Dr. Makhzoumi graduated from University of Maryland School of Medicine in 2008. Dr. Makhzoumi holds Maryland license D0075407.

Dr. Makhzoumi's primary practice is University of Maryland Surgical Center, at 419 W Redwood St, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-4080.

Dr. Makhzoumi's primary practice is University of Maryland Surgical Center in Baltimore, Maryland. The medical group on file is University of Maryland Dermatology. Dmand AI also links Dr. Makhzoumi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Makhzoumi practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Makhzoumi's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Makhzoumi is licensed in Maryland.

CMS data shows 3,661 Medicare services from Dr. Makhzoumi across 25 procedure codes in 2024, for 832 Medicare patients. Medicare paid $751,568 for them. Every service was in an office.

CMS counts 832 Medicare patients who saw Dr. Makhzoumi in 2024. The largest group is 75 to 84, with 377 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Makhzoumi's median patient age at 66, with 46% women.

In 2024, Dr. Makhzoumi wrote 90 Medicare Part D claims for 52 patients. 98% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $2,949 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Makhzoumi for performance year 2024, reported as part of a group. Dr. Makhzoumi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 114 procedures of melanoma (skin cancer) excision by Dr. Makhzoumi, more than 94% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Makhzoumi in 2015. 2015 was the busiest year, with 3. Dr. Makhzoumi has published most often in Dermatol Surg. Dr. Makhzoumi's most frequent co-authors are Sarah Tuttleton Arron, MD, PhD, Conroy L. Chow, MD and Christian R. Halvorson, MD.

CMS Open Payments shows 28 general payments to Dr. Makhzoumi from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Sanofi and Genzyme US Companies paid the most, $4,786.

Dr. Makhzoumi graduated from University of Maryland School of Medicine in 2008.